Wild wheat relative genes to aid in battle against trio of pests
Wheat curl mite, greenbug and Hessian fly have long been troublemaker pests for Texas wheat, but a team of Texas A&M AgriLife Research scientists is...
Continue ReadingIndian generic industry loses a titan in DG Shah
D G Shah had a larger imprint on the pharma industry than what his job title — secretary general of the Indian Pharmaceutical Alliance (IPA)...
Continue ReadingFDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
A key element of the U.S. Food and Drug Administration’s mission is focused on helping to ensure that all products we regulate, including drugs available...
Continue ReadingGlenmark Pharma appoints CEO for its new innovation company
Glenmark Pharmaceuticals has announced the appointment of Alessandro Riva as the CEO of its new innovation company.Mr. Riva is currently Executive Vice President, Oncology Therapeutics...
Continue ReadingUS FDA chief’s exit could impact Indian pharma
The abrupt exit of the US FDA commissioner Scott Gottlieb after a nearly 2-year stint under the Trump administration throws Indian pharma into uncertainty on...
Continue ReadingIndia gets tough on generics quality issues and cancer drug prices
Even as more blood pressure drugs are being recalled in the USA after being found to contain trace amounts of a potentially cancer-causing ingredient, India’s...
Continue ReadingSuven plans to buy US-based Rising Pharmaceuticals’ assets
Suven Life Sciences through its joint venture partner, Shore Suven Pharma, has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto...
Continue ReadingUSFDA lifts warning letter on Dr Reddy’s Duvvada plant in Andhra Pradesh
This is the second plant to come out of the warning letter after multiple inspections conducted by the US drug regulator. In a major relief to...
Continue ReadingBig relief for cancer patients: 30% margin on medicines to reduce prices, benefit poor
The healthcare industry has hailed the Modi government for capping 30 per cent margin on 42 drugs meant for the cancer patients. The industry insiders...
Continue Reading